SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics shares surged on positive topline results from its VK2735 obesity maintenance study, showing substantial weight-loss retention on less frequent dosing and no plateau at 33 weeks. Traders are split between strong bullish conviction  citing best-in-class claims, heavy short interest, and potential buyout interest from Novo Nordisk or other big pharma  and skepticism over the muted price reaction, expected dilution from a shelf offering, and the possibility of a post-data fade.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending on its first Alloy Kore design win, with Coretura (backed by Daimler Truck and Volvo Group) selecting the QNX/Vector software platform in a deal reportedly worth over $100 million, pushing QNX backlog toward or past $1 billion. Sentiment is sharply split: bulls see the win as proof of concept ahead of upcoming Q2 earnings, while bears note the muted stock reaction, calling the news a 

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

GOOGL is seeing sharp intraday selling and volatility that traders attribute largely to macro forcesrising yields and the Fed's first rate hike in yearsrather than company-specific news, with the stock repeatedly failing to hold levels around $350. Some community discussion also ties weakness to Netflix downgrades highlighting YouTube's streaming gains and to AI-related headlines, while bulls view the dip as a buying opportunity versus bears calling the stock overvalued.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

Traders are reacting to a sharp single-session selloff in DKNG, with discussion centering on a viral New York Times report alleging DraftKings uses AI to target losing bettors with promotions, alongside concerns about a customer-friendly NFL Week 1 hold and mounting competition from prediction markets like Kalshi and Polymarket. The community is split between bears citing competitive and regulatory pressure on the sportsbook model and bulls pointing to record DKeX prediction-market volumes and strong handle as signs the selloff is overdone.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance's settlement with 12 state attorneys general and the Writers Guild cleared the main legal obstacles to its acquisition of Warner Bros. Discovery, with the CEO telling staff the deal is targeted to close in roughly two weeks, avoiding further daily ticking fees. Community reaction is sharply divided: bulls tout the combined content library, synergies, and analyst upgrades, while skeptics frame the muted stock response as a 'sell the news' event, citing deal debt, dilution concerns, and claims of heavy short-selling pressure.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco shares are sharply lower, and traders are debating a Piper Sandler analyst move that cut the price target on the stock while keeping a Neutral ratingsome posters are calling it a downgrade, while others argue the rating was unchanged and the sell-off is overdone. The move has fueled heavy volume, with dip-buyers loading up and frustrated holders questioning why fundamentally strong earnings are being ignored.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

The U.S.-Denmark-Greenland Arctic security agreement dominates the conversation, with traders speculating that closer U.S. ties to Greenland could accelerate investment in and development of Critical Metals' Tanbreez rare earth project. Bulls point to possible U.S. government funding or a stake and elevated short interest as squeeze fuel, while bears call it a sell-the-news event, noting the agreement contains no direct mining or financing provisions.

Alphabet Inc - Ordinary Shares - Class C

GOOG is drawing attention for persistent underperformance versus rallying AI peers like Meta, AMD, and Microsoft, with traders split between frustration that the stock bleeds on green market days and bulls arguing its sub-20 P/E makes it deeply undervalued. The debate also touches on speculation about Gemini 4 and Google's AI standing, though that remains unconfirmed rumor.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending around its removal from the S&P 500 and move to the S&P SmallCap 600, with heavy index-related volume and selling dominating the discussion. Sentiment is sharply divided: many traders blame CEO Jeff Green, executive stock grants/option repricing, layoffs, and slowing growth, while others argue the stock is deeply oversold with elevated short interest setting up a potential rebound or short squeeze.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as founder Patrick Soon-Shiong teased a potential push into blockchain-based tokenized stock trading at his Nant companies, sparking retail speculation that IBRX shares could eventually be tokenized and limit short-selling. Community discussion is split between bullish excitement over tokenization, upcoming international expansion (including chatter about a possible Turkey approval), and expected Anktiva label-expansion catalysts, alongside skeptics who see the hype as unsubstantiated and worry about continued price weakness.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

All You Need to Know About Actuate Therapeutics, Inc. (ACTU) Rating Upgrade to Buy

Actuate Therapeutics, Inc. (ACTU) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Short Interest in Actuate Therapeutics, Inc. (NASDAQ:ACTU) Grows By 40.1%

Actuate Therapeutics, Inc. (NASDAQ:ACTU - Get Free Report) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totaling 914,989 shares, an increase of 40.1% from the March 31st total of 653,203 shares. Currently, 12.6% of the company's...

HC Wainwright Reiterates "Buy" Rating for Actuate Therapeutics (NASDAQ:ACTU)

HC Wainwright reaffirmed a "buy" rating and set a $15.00 target price on shares of Actuate Therapeutics in a research note on Wednesday...

Why Did Actuate Therapeutics (ACTU) Stock Jump Over 14% After Hours?

Actuate Therapeutics shares surged 14.41% after-hours after Nature Medicine published Phase 2 data showing elraglusib plus chemotherapy improved overall survival in metastatic pancreatic cancer.read...

Actuate Therapeutics (NASDAQ:ACTU) Raised to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Actuate Therapeutics from a "sell" rating to a "hold" rating in a report on Saturday...

Voss Capital LP Boosts Stake in Actuate Therapeutics, Inc. $ACTU

Voss Capital LP raised its holdings in shares of Actuate Therapeutics, Inc. (NASDAQ:ACTU - Free Report) by 213.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities...

Actuate Therapeutics (NASDAQ:ACTU) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen downgraded shares of Actuate Therapeutics from a "hold" rating to a "sell" rating in a report on Saturday...

Actuate Therapeutics (NASDAQ:ACTU) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded Actuate Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Mettler-Toledo Q4 Earnings Top Estimates, Sales Rise Y/Y

MTD beats Q4 estimates as adjusted EPS jumps 8% Y/Y and sales rise to $1.13B, led by solid growth across Laboratory, Industrial and Food Retail.

Actuate Therapeutics, Inc. (NASDAQ:ACTU) Sees Significant Growth in Short Interest

Actuate Therapeutics, Inc. (NASDAQ:ACTU - Get Free Report) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totaling 529,786...

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Actuate Therapeutics Inc.

Actuate Therapeutics Stock Rises After Updating FDA Application For Lead Investigational Drug In Treating Pancreatic Cancer

Equity

Neutral Sentiment

Job displacement

Market bubble / overvaluation

Loss of human oversight / control

Killer robots 🤖

As AI spending accelerates across hyperscalers and valuations climb to historic highs, investors and workers alike are increasingly debating the risks the technology poses - from job displacement to fears about losing human oversight over increasingly autonomous systems. What do you think is the biggest threat AI poses? Vote and explain your reasoning in the comments.

Feed

News

Sentiment

Earnings

Fundamentals

Info

ACTU Actuate Therapeutics Inc.

Fundamentals

Latest ACTU News